MARCOTULLIO , S.

Last name: MARCOTULLIO

First name: S.

2015 (v1)

Publication

Metadata-only

An update on integrase inhibitors: New opportunities for a personalized therapy?: The NEXTaim Project

Andreoni, M. Marcotullio, S. Puro, V.

No description

Uploaded on: February 11, 2024
2016 (v1)

Publication

Metadata-only

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015

Antinori, A. Marcotullio, S. Andreoni, M.

No description

Uploaded on: May 12, 2023
2015 (v1)

Publication

Metadata-only

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

Mussini, Cristina Lorenzini, Patrizia Puoti, Massimo

Objective: To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART). Design: Retrospective analysis of a prospective cohort study. Setting: Italian HIV care centers...

Uploaded on: May 13, 2023
2016 (v1)

Publication

Metadata-only

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort

Saracino, A. Lorenzini, P. Lo Caputo, S.

Migrant and Italian HIV-infected patients (n = 5773) enrolled in the ICONA cohort in 2004-2014 were compared for disparities in access to an initial antiretroviral regimen and/or risk of virologic failure (VF), and determinants of failure were evaluated. Variables associated with initiating antiretroviral therapy (ART) were analysed. Primary...

Uploaded on: April 14, 2023
2015 (v1)

Publication

Metadata-only

Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy

Bandera, Alessandra Gori, Andrea Sabbatini, Francesca

No description

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

Madeddu, Giordano Rusconi, Stefano Cozzi Lepri, Alessandro

Background: Nucleos(t)ide reverse transcriptase inhibitors (NRTI) toxicity may represent a threat for long-term success of combined antiretroviral therapy. Some studies have suggested a possible improvement of NRTI-related toxicity after switching to NRTI-sparing regimens. Objectives: We aimed to explore the efficacy and tolerability of...

Uploaded on: April 14, 2023

MARCOTULLIO , S.

Recent uploads